-
Company Insights
NewApple Pay – Competitor Profile
Apple Pay is a mobile payment solution launched by Apple in October 2014. It allows users to store their payment card details to use for future payments. Users hover their mobile device near a contactless terminal and authenticate the transaction via Touch ID, Face ID, or PIN depending on the Apple device used. The solution is accepted at millions of retail outlets globally and supports all major payment networks. Apple Pay is supported by more than 6,600 banks and financial...
-
Product Insights
NewComputed Tomography (CT) Systems Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Computed Tomography (CT) Systems Pipeline Market Report Overview Computed Tomography (CT) is a powerful and non-destructive evaluation technique used for producing 2D and 3D cross-sectional images of an object from a flat X-ray image. It is used on patients with a high risk of colon cancer or full-motion heart scans for patients with a high risk of heart disease. The CT systems pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at...
-
Sector Analysis
NewUnited Kingdom (UK) Home Kitchen Furniture Market Trends, Analysis, Consumer Dynamics and Spending Habits
The UK: Home Category Data, The Consumer - Kitchen furniture 2024 report offers a comprehensive insight into consumer attitudes in the UK kitchen furniture market. The report focuses on six key subcategories: overall kitchen furniture, sinks & taps, kitchen cabinets, cupboard doors & accessories, worktops, and under counter lighting. Consumer data is based on our 2024 UK kitchen furniture survey, using a panel of 2,000 nationally representative consumers.
-
Company Insights
NewHartford Financial Services Group Inc. – Digital Transformation Strategies
Hartford Health Digital Transformation Strategies Overview Hartford is tapping the power of big data analytics to analyze data and generate insights, improve member engagement, and detect fraudulent claims. AI, big data, cloud, cybersecurity, and IoT are among the key technologies under focus for the company. The annual ICT spending of Hartford was estimated at $549 million in 2023. A major share of this spending is earmarked for acquiring software, network and communications, and hardware from vendors. The Hartford Financial Services...
-
Company Insights
NewDecoding Oreo’s YouTube Advertising Strategy in Q1 2024
The report on Oreo's advertising strategies on YouTube during the first quarter of 2024, focuses on key products such as Oreo Pacman, Oreo Pokemon, and Oreo Enrobed White. It analyzes the core themes, messaging strategies, and product benefits portrayed in these advertisements, highlighting elements such as Twist on it, Visual Appeal and Sensory Experience. Moreover, the report examines the overarching themes of Playful Tone, Humor and Engaging Characters infused into these campaigns. By synthesizing these insights, the report aims to...
-
Analyst Opinions
NewIndia Wealth Management – High Net Worth (HNW) Investors
India Wealth Management Market Report Overview The Indian HNW market is dominated by older and professional males. HNW investors have mainly sourced their wealth from earned income; entrepreneurial income and inheritance form smaller yet growing sources. In a highly competitive market such as this, advisory mandates have the highest demand, yet offering a multi-service proposition underpinned by a proven ability to demonstrate returns will be key to tapping into demand. Growing appetite for managed mandates and alternative investments provides arguably...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TPIV-110 in Ductal Carcinoma In Situ
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TPIV-110 in Ductal Carcinoma In Situ report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. TPIV-110 in Ductal Carcinoma In Situ Drug Details: TPIV-110...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Naratuximab Emtansine in Non-Hodgkin Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Naratuximab Emtansine in Non-Hodgkin Lymphoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Naratuximab Emtansine in Non-Hodgkin Lymphoma Drug Details: Naratuximab emtansine is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Naratuximab Emtansine in Marginal Zone B-cell Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Naratuximab Emtansine in Marginal Zone B-cell Lymphoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Naratuximab Emtansine in Marginal Zone B-cell Lymphoma Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Naratuximab Emtansine in Diffuse Large B-Cell Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Naratuximab Emtansine in Diffuse Large B-Cell Lymphoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Naratuximab Emtansine in Diffuse Large B-Cell Lymphoma Drug...